Learnt to take little notice of the bio reactions of the asx, or...

Learnt to take little notice of the bio reactions of the asx, or the 'delay-sx' as i call it. Its needs a media article or OS catalyst to be convinced a bio is worth it. I laugh at PBT's movements often requiring a nasdaq performance before reacting to asx released anns, and whilst not the same here as we arent listed in the us, it does point to a mentality. that we are 2 days before xmas is also telling. Traders may have taken this for a ride on Friday IMO.

Regardless, im upbeat. We had one patient with very low reduction, ( perhaps not a causative dosage/kg relationship, perhaps the weight issue was of endocrinological cause, who knows at this point)What is positive is that the co. now seems to have license to up the dose at a later date, perhaps a bariatric dose may make all the difference to such patients.

One would think that weight/kg boundaries will need to be explored anyway for clinical titration purposes, although if few Se's are found then this point may be moot.